Rapid In Vivo Screening of Experimental Drugs for Tuberculosis Using Gamma Interferon Gene-Disrupted Mice

We have developed a rapid new in vivo method for screening experimental drugs for their activity against Mycobacterium tuberculosis by using the gamma interferon gene-disrupted (GKO) C57BL/6 mouse. Due to the rapid growth of the infection, statistical differences indicating positive efficacy of acti...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Lenaerts, Anne J. M., Gruppo, Veronica, Brooks, Jason V., Orme, Ian M.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2003
Schlagworte:	Experimental Therapeutics
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151769/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12543692/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.2.783-785.2003
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!